The World Bank (WB) and the International Monetary Fund (IMF) categorize their members according to the level of per capita gross domestic product (GDP).

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

Cancer is becoming a global crisis shaped less by biology than by inequality, risk exposure, and access to care.

Introduction More than 75% of the global population resides in low- and middle-income countries (LMICs), where ...

Participation from lower middle-income countries still limited overall, accounting for fewer than 5% of all studies registered over the past three decades.

More than 80 per cent of genomic studies across the world looking into diseases are concentrated in high-income countries, ...

Patients in high-income countries generally have access to innovative and effective cancer treatment. However, in almost half of low- and middle-income countries, cancer drugs considered essential by ...

A recent World Health Organization (WHO) analysis reveals that less than 5% of disease-focused genomic studies are conducted ...

Central Asia and the Caucasus saw solid growth, new transport corridors and multi-vector diplomacy in 2025, even as conflicts ...